Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review.
Peter MohrFelix KieckerVirtudes SorianoOlivier DereureKarmele MujikaPhilippe SaiagJochen UtikalRama KoneruCaroline RobertFlorencia CuadrosMatias ChacónRodrigo U VillarroelYana G NajjarLisa KottschadeEva M CouseloRoy KoruthAnnie GuérinRebecca BurneRaluca Ionescu-IttuMaurice PerrinjaquetJonathan S ZagerPublished in: Melanoma management (2019)
Adjuvant therapies with better safety/efficacy profiles will improve clinical outcomes in patients with stage III melanoma.